Shane Burgess
Chief Executive Officer at Tio Bioventures
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Bray | M | 58 |
Tio Bioventures
 Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York.
Treadwell Therapeutics, Inc.
 Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | 5 years |
| Tak-Wah Mak | M | 77 |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY.
Tio Bioventures
Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York. | - |
| Michael W. Tusche | M | - |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY.
Tio Bioventures
Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York. | - |
| Qi-Feng Jiang | M | 40 |
Simon Fraser University
| 19 years |
| Trevor Burgess | M | - |
VoltSafe, Inc.
 VoltSafe, Inc. Industrial ConglomeratesProducer Manufacturing VoltSafe, Inc. engages in providing magnetic engine block heater plugs. The company was founded by Trevor Burgess and Arash Janfada and is headquartered in Vancouver, CA. | - |
| Arash Janfada | M | - |
VoltSafe, Inc.
VoltSafe, Inc. Industrial ConglomeratesProducer Manufacturing VoltSafe, Inc. engages in providing magnetic engine block heater plugs. The company was founded by Trevor Burgess and Arash Janfada and is headquartered in Vancouver, CA. | - |
| Ryan Dietz | M | - |
Tio Bioventures
Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York.
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | 4 years |
| Roger Sidhu | M | 48 |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | - |
| Isan Chen | M | 61 |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | - |
| Philip Duong | M | 34 |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Chan | M | - |
The University of Waterloo
| 5 years |
| Rachel Humphrey | M | 62 |
Tio Bioventures
Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York.
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | - |
| Ka Leung Chan | M | 51 |
The University of Waterloo
| 4 years |
| Rahim Suleman | M | - |
The University of Waterloo
| 5 years |
| Abe Goenka | M | - |
The University of Waterloo
| 5 years |
| Daniel Im | M | - |
The University of Waterloo
| 5 years |
| Xin Chen | F | - |
Simon Fraser University
| 4 years |
| Kristian Bauer | M | - |
The University of Waterloo
| 6 years |
| Andrew MacNeil | M | - |
Simon Fraser University
The University of Waterloo
| 7 years |
| Andrew Roszko | M | - |
The University of Waterloo
| 7 years |
| Rohan Thiru | M | - |
The University of Waterloo
| 5 years |
| Sanjeev Motwani | M | - |
The University of Waterloo
| 5 years |
| Tony Chernis | M | - |
Simon Fraser University
| 5 years |
| Xiang Lin Li | M | 61 |
The University of Waterloo
| 4 years |
| Cosmos Chiu | M | - |
The University of Waterloo
| 5 years |
| Keith Lam | M | - |
The University of Waterloo
| 5 years |
| Angus Wai | M | - |
The University of Waterloo
| 5 years |
| Adam J. Petryk | M | - |
The University of Waterloo
| 7 years |
| Don DeMarco | M | - |
The University of Waterloo
| 8 years |
| Wendy Alexandra Franks | M | - |
The University of Waterloo
| 7 years |
| Russell French | M | - |
The University of Waterloo
| 5 years |
| Prateek Dwivedi | M | 53 |
The University of Waterloo
| 7 years |
| Gary Fung | M | - |
The University of Waterloo
| 5 years |
| Chris Heakes | M | - |
The University of Waterloo
| 4 years |
| Mark Tan | M | 43 |
The University of Waterloo
| 4 years |
| Brett Barnes | M | - |
The University of Waterloo
| 4 years |
| Stephen Poitras | M | - |
The University of Waterloo
| 5 years |
| Nick Piquard | M | - |
The University of Waterloo
| 5 years |
| Ka Yan Shiu | F | 45 |
The University of Waterloo
| 4 years |
| Joyce Lee | F | - |
The University of Waterloo
| 4 years |
| Mohsin Ahmed Bashir | M | - |
The University of Waterloo
| 5 years |
| Michael Volker | M | 76 |
The University of Waterloo
| 6 years |
| Cheuk Yin Chow | M | - |
The University of Waterloo
| 4 years |
| Jason R.B. Maguire | M | - |
The University of Waterloo
| 4 years |
| Edward Beggs | M | - |
The University of Waterloo
| 4 years |
| Xin Guan | F | 42 |
The University of Waterloo
| 4 years |
| Saurabh Moudgil | M | - |
The University of Waterloo
| 4 years |
| Adatia Alisha | F | - |
The University of Waterloo
| 5 years |
| Anish Acharya | M | - |
The University of Waterloo
| 4 years |
| Christopher Clark | M | - |
The University of Waterloo
| 4 years |
| David Hung | M | - |
The University of Waterloo
| 4 years |
| Salman Hoda | M | 44 |
The University of Waterloo
| 4 years |
| Steven Bowles | M | - |
The University of Waterloo
| 5 years |
| Kazeem Jaffer | M | - |
The University of Waterloo
| 4 years |
| Trinh Joseph | M | - |
The University of Waterloo
| 2 years |
| Oshoma Momoh | M | - |
The University of Waterloo
| 5 years |
| Selwyn Yuen | M | - |
The University of Waterloo
| 5 years |
| Kim Samantha | F | - |
The University of Waterloo
| 4 years |
| Patrick Lamarre | M | 52 |
The University of Waterloo
| 4 years |
| Amit Chakma | M | 65 |
The University of Waterloo
| 8 years |
| Kevin Madill | M | - |
The University of Waterloo
| 5 years |
| Jamie Winton | M | - |
The University of Waterloo
| 4 years |
| Jim R. Moore | M | - |
The University of Waterloo
| 5 years |
| Jin Choi | M | - |
The University of Waterloo
| 4 years |
| Deepak Kaushal | M | - |
The University of Waterloo
| 5 years |
| Timothy C. Wang | M | - |
The University of Waterloo
| 4 years |
| Thomas Pistor | M | 52 |
The University of Waterloo
| 4 years |
| William Jee | M | - |
The University of Waterloo
| 5 years |
| Juliana Sponer | F | - |
The University of Waterloo
| 4 years |
| Herman Singh Gill | M | - |
The University of Waterloo
| 4 years |
| Ashvin Viswanathan | M | - |
The University of Waterloo
| 5 years |
| David Ascott | M | - |
The University of Waterloo
| 4 years |
| Marc Faucher | M | - |
The University of Waterloo
| 4 years |
| David Johnston | M | 83 |
The University of Waterloo
| - |
| Jonathan Shui | M | - |
The University of Waterloo
| 5 years |
| Ka On Cheng | M | 74 |
The University of Waterloo
| 3 years |
| Linda Ezergailis | F | - |
The University of Waterloo
| 5 years |
| K. Ian McPhee | M | - |
The University of Waterloo
| 3 years |
| Barbara A. Paldus | M | 54 |
The University of Waterloo
| 5 years |
| E. B. Cross | M | - |
The University of Waterloo
| 14 years |
| Kurtis N. McBride | M | - |
The University of Waterloo
| 4 years |
| Gorica Djeric | F | - |
The University of Waterloo
| 5 years |
| R. Scott McKinley | M | 68 |
The University of Waterloo
| 3 years |
| Perry Siu | M | - |
The University of Waterloo
| 5 years |
| Nicholas Kim | M | - |
The University of Waterloo
| 5 years |
| Dana John Love | M | - |
The University of Waterloo
| 4 years |
| Christopher Ireland | M | 54 |
The University of Waterloo
| 5 years |
| Ryan Li | M | - |
The University of Waterloo
| 5 years |
| Ray Reddy | M | - |
The University of Waterloo
| 4 years |
| Francisco Lung | M | - |
The University of Waterloo
| 5 years |
| Jason Hsiao Chen | M | - |
The University of Waterloo
| 5 years |
| Jeffery Coles | M | - |
The University of Waterloo
| 5 years |
| Dalton Baretto | M | - |
The University of Waterloo
| 4 years |
| Grant Beasley | M | - |
The University of Waterloo
| 4 years |
| Wing-Hei Wilkins Chung | M | - |
The University of Waterloo
| 5 years |
| Bo Xiong Lan | M | 74 |
The University of Waterloo
| 3 years |
| Hanif Merali | M | - |
The University of Waterloo
| 5 years |
| John Tryhub | M | - |
The University of Waterloo
| 4 years |
| Matthew Black | M | - |
The University of Waterloo
| 4 years |
| Richard Orrell | M | - |
The University of Waterloo
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 92 | 92.00% |
| United States | 8 | 8.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Shane Burgess
- Personal Network
